IQVIA (IQV) Competitors

Bruker (NASDAQ:BRKR) and IQVIA (NYSE:IQV) are related companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, profitability, risk, earnings, valuation, institutional ownership and media sentiment.

Does the media favor BRKR or IQV?

In the previous week, IQVIA had 6 more articles in the media than Bruker. MarketBeat recorded 16 mentions for IQVIA and 10 mentions for Bruker. IQVIA's average media sentiment score of 1.13 beat Bruker's score of 0.89 indicating that IQVIA is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Bruker	6 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
IQVIA	13 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do analysts prefer BRKR or IQV?

Bruker currently has a consensus target price of $52.89, indicating a potential upside of 30.43%. IQVIA has a consensus target price of $222.45, indicating a potential upside of 38.27%. Given IQVIA's stronger consensus rating and higher possible upside, analysts clearly believe IQVIA is more favorable than Bruker.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bruker	0 Sell rating(s)	6 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.40
IQVIA	0 Sell rating(s)	7 Hold rating(s)	16 Buy rating(s)	1 Strong Buy rating(s)	2.75

Do institutionals & insiders have more ownership in BRKR or IQV?

79.5% of Bruker shares are held by institutional investors. Comparatively, 89.6% of IQVIA shares are held by institutional investors. 27.3% of Bruker shares are held by insiders. Comparatively, 1.6% of IQVIA shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Which has more volatility & risk, BRKR or IQV?

Bruker has a beta of 1.18, suggesting that its stock price is 18% more volatile than the S&P 500. Comparatively, IQVIA has a beta of 1.3, suggesting that its stock price is 30% more volatile than the S&P 500.

Is BRKR or IQV more profitable?

IQVIA has a net margin of 8.61% compared to Bruker's net margin of 2.31%. IQVIA's return on equity of 29.16% beat Bruker's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bruker	2.31%	19.47%	5.95%
IQVIA	8.61%	29.16%	6.96%

Which has preferable valuation and earnings, BRKR or IQV?

IQVIA has higher revenue and earnings than Bruker. IQVIA is trading at a lower price-to-earnings ratio than Bruker, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bruker	$3.45B	1.78	$113.10M	$0.52	77.98
IQVIA	$15.41B	1.81	$1.37B	$7.34	21.92

Summary

IQVIA beats Bruker on 15 of the 17 factors compared between the two stocks.